Many emerging e-commerce brands may merely be flash-in-the-pan phenomena, but P&G is investing significantly in e-commerce and digital marketing to “win mobile back,” according to CEO David Taylor. The firm also will continue to strengthen the mid and value tiers of its shave business, he said during a Q4 earnings call in which Unilever’s Dollar Shave Club acquisition was on a number of analysts’ minds.
Procter & Gamble Co. discussed its digital marketing and e-commerce platforms, openness to strategic acquisitions and moves being made to strengthen its presence in lower-tier shave segments during the firm’s fiscal 2016 fourth-quarter earnings call.
Much of the discussion around those subjects stemmed from analyst questions about P&G’s outlook on Unilever PLC’s acquisition of...
Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.
Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.
